1-5 of 5
Terence O'Reilly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis

Moriko Ito, Louise Barys, Terence O'Reilly, Sophie Young, Bella Gorbatcheva, John Monahan, Sabine Zumstein-Mecker, Peter F. Choong, Ian Dickinson, Philip Crowe, Christine Hemmings, Jayesh Desai, David M. Thomas, Joanna Lisztwan
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (3): 416–426.
https://doi.org/10.1158/1078-0432.CCR-10-2050
Published: 01 February 2011
View article titled, Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and <em>MDM2</em> Amplification in Sarcomagenesis
Open the PDF for Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and <em>MDM2</em> Amplification in Sarcomagenesis in another window
Includes: Supplementary data
Journal Articles

mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor

Heidi A. Lane, Jeanette M. Wood, Paul M.J. McSheehy, Peter R. Allegrini, Anne Boulay, Joseph Brueggen, Amanda Littlewood-Evans, Sauveur-Michel Maira, Georg Martiny-Baron, Christian R. Schnell, Patrizia Sini, Terence O'Reilly
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (5): 1612–1622.
https://doi.org/10.1158/1078-0432.CCR-08-2057
Published: 27 February 2009
View article titled, mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor
Open the PDF for mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor in another window
Includes: Supplementary data
Journal Articles

Patupilone Induced Vascular Disruption in Orthotopic Rodent Tumor Models Detected by Magnetic Resonance Imaging and Interstitial Fluid Pressure

Stephane Ferretti, Peter R. Allegrini, Terence O'Reilly, Christian Schnell, Michael Stumm, Markus Wartmann, Jeanette Wood, Paul M.J. McSheehy
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7773–7784.
https://doi.org/10.1158/1078-0432.CCR-05-1165
Published: 08 November 2005
View article titled, Patupilone Induced Vascular Disruption in Orthotopic Rodent Tumor Models Detected by Magnetic Resonance Imaging and Interstitial Fluid Pressure
Open the PDF for Patupilone Induced Vascular Disruption in Orthotopic Rodent Tumor Models Detected by Magnetic Resonance Imaging and Interstitial Fluid Pressure in another window
Journal Articles

Dual Inhibition of mTOR and Estrogen Receptor Signaling In vitro Induces Cell Death in Models of Breast Cancer

Anne Boulay, Joelle Rudloff, Jingjing Ye, Sabine Zumstein-Mecker, Terence O'Reilly, Dean B. Evans, Shiuan Chen, Heidi A. Lane
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (14): 5319–5328.
https://doi.org/10.1158/1078-0432.CCR-04-2402
Published: 20 July 2005
View article titled, Dual Inhibition of mTOR and Estrogen Receptor Signaling <em>In vitro</em> Induces Cell Death in Models of Breast Cancer
Open the PDF for Dual Inhibition of mTOR and Estrogen Receptor Signaling <em>In vitro</em> Induces Cell Death in Models of Breast Cancer in another window
Journal Articles

The Antitumor and Antiangiogenic Activity of Vascular Endothelial Growth Factor Receptor Inhibition Is Potentiated by ErbB1 Blockade

Patrizia Sini, Lorenza Wyder, Christian Schnell, Terence O'Reilly, Amanda Littlewood, Ralph Brandt, Nancy E. Hynes, Jeanette Wood
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (12): 4521–4532.
https://doi.org/10.1158/1078-0432.CCR-04-1954
Published: 15 June 2005
View article titled, The Antitumor and Antiangiogenic Activity of Vascular Endothelial Growth Factor Receptor Inhibition Is Potentiated by ErbB1 Blockade
Open the PDF for The Antitumor and Antiangiogenic Activity of Vascular Endothelial Growth Factor Receptor Inhibition Is Potentiated by ErbB1 Blockade in another window